ICDcodes.org
FY2027

E08.3312Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye

Billable

Is E08.3312 billable?

Yes — E08.3312 is billable for FY2027. E08.3312 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. E08.3312 may be submitted for encounters from October 1, 2026 through September 30, 2027.

E08.3312 at a glance

CodeE08.3312
DescriptionDiabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027
7th character "2"left eye

What does the 7th character "2" mean in E08.3312?

In E08.3312, the 7th character 2 means left eye. The 7th character is required for E08.3312 to be a valid, complete code.

Same condition, different episode of care — switch the 7th character:

What Medicare edits apply to E08.3312?

The Medicare Code Editor screens inpatient claims before they are grouped. These edits name E08.3312 directly.

Manifestation code — never sequenced first — MCE edit 6

This code describes a manifestation of an underlying disease. The underlying condition must be sequenced before it, so it can never be the principal or first-listed diagnosis.

Which MS-DRGs does E08.3312 group to?

E08.3312 sits in MDC Pre and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 008Simultaneous Pancreas, Islet Cell and Kidney Transplantsurgical

How is E08.3312 listed in the Alphabetic Index?

The Alphabetic Index lists these routes under E08.331, the nearest indexed parent of E08.3312. Use them to find the family, then select the specific code.

  • Diabetes, diabeticdue to underlying conditionwithretinopathynonproliferativemoderatewith macular edema (mellitus) (sugar)

Excludes1 — never code together — inherited from Chapter 4

The conditions below can never be reported together with E08.3312 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)

Excludes1 — never code together — inherited from E08

The conditions below can never be reported together with E08.3312 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
  • type 2 diabetes mellitus (E11.-)

Code first — inherited from E08

The underlying condition below must be sequenced before E08.3312. E08.3312 describes a manifestation and cannot be the principal or first-listed diagnosis.

  • the underlying condition, such as:
  • congenital rubella (P35.0)
  • Cushing's syndrome (E24.-)
  • cystic fibrosis (E84.-)
  • malignant neoplasm (C00-C96)
  • malnutrition (E40-E46)
  • pancreatitis and other diseases of the pancreas (K85-K86.-)

Use additional code — inherited from E08

Report an additional code alongside E08.3312 to fully describe the condition. E08.3312 is sequenced first.

  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)

How long has E08.3312 existed?

E08.3312 first appears in FY2018 (FY2017 is not available, so it may have appeared then).

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.